Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1963
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1968 1
1969 2
1970 1
1971 2
1974 1
1975 2
1976 4
1977 1
1979 1
1981 6
1982 4
1983 1
1984 3
1986 1
1987 1
1988 3
1989 4
1990 8
1991 6
1992 3
1993 6
1994 8
1995 4
1996 9
1997 6
1998 1
1999 5
2000 1
2002 3
2003 7
2004 7
2005 11
2006 8
2007 4
2008 10
2009 5
2010 7
2011 7
2012 4
2013 9
2014 9
2015 11
2016 11
2017 10
2018 13
2019 18
2020 21
2021 13
2022 17
2023 22
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB. Hendry S, et al. Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Adv Anat Pathol. 2017. PMID: 28777143 Free PMC article. Review.
In part 1 of this review, we have proposed a standardized methodology to assess tumor-infiltrating lymphocytes (TILs) in solid tumors, based on the International Immuno-Oncology Biomarkers Working Group guidelines for invasive breast carcinoma. In part 2 of this review, we …
In part 1 of this review, we have proposed a standardized methodology to assess tumor-infiltrating lymphocytes (TILs) in solid tumors, based …
An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.
Bellizzi AM. Bellizzi AM. Adv Anat Pathol. 2020 May;27(3):114-163. doi: 10.1097/PAP.0000000000000256. Adv Anat Pathol. 2020. PMID: 32205473 Free PMC article. Review.
Specific topics covered in this review include (1) broad tumor classification and associated screening markers; (2) the role of cancer epidemiology in determining pretest probability; (3) broad-spectrum epithelial markers; (4) noncanonical expression of broad tumor class screenin …
Specific topics covered in this review include (1) broad tumor classification and associated screening markers; (2) the role of cancer epide …
Naringenin: A potential flavonoid phytochemical for cancer therapy.
Motallebi M, Bhia M, Rajani HF, Bhia I, Tabarraei H, Mohammadkhani N, Pereira-Silva M, Kasaii MS, Nouri-Majd S, Mueller AL, Veiga FJB, Paiva-Santos AC, Shakibaei M. Motallebi M, et al. Life Sci. 2022 Sep 15;305:120752. doi: 10.1016/j.lfs.2022.120752. Epub 2022 Jun 29. Life Sci. 2022. PMID: 35779626 Review.
Collected data from in vitro and in vivo studies show the inactivation of carcinogens after treatment with pure naringenin, naringenin-loaded nanoparticles, and also naringenin in combination with anti-cancer agents in various malignancies, such as colon cancer, lung neoplasms, b …
Collected data from in vitro and in vivo studies show the inactivation of carcinogens after treatment with pure naringenin, naringenin-loade …
Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Deli T, Orosz M, Jakab A. Deli T, et al. Pathol Oncol Res. 2020 Jan;26(1):63-78. doi: 10.1007/s12253-018-00569-x. Epub 2019 Jan 8. Pathol Oncol Res. 2020. PMID: 30617760 Free PMC article. Review.
More and more of them live long enough to reach either the natural age of menopause or, as a side effect of their oncotherapy, experience the cessation of gonadal function, leading to premature ovarian insufficiency, with disturbing vasomotor symtoms and long-term negative …
More and more of them live long enough to reach either the natural age of menopause or, as a side effect of their oncotherapy, experience th …
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Mosele F, et al. Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24. Ann Oncol. 2020. PMID: 32853681 Free article. Review.
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lung cancer (NSCLC), prostate cancers, ovarian cancers and cholangiocarcinoma. ...In addition, based on the KN158 trial and considering …
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lu …
Tumor-derived exosomes in the regulation of macrophage polarization.
Baig MS, Roy A, Rajpoot S, Liu D, Savai R, Banerjee S, Kawada M, Faisal SM, Saluja R, Saqib U, Ohishi T, Wary KK. Baig MS, et al. Inflamm Res. 2020 May;69(5):435-451. doi: 10.1007/s00011-020-01318-0. Epub 2020 Mar 11. Inflamm Res. 2020. PMID: 32162012 Review.
The review is divided into two main parts, as follows: (1) role of exosomes in alternatively activating M2-like macrophages-breast cancer-derived exosomes, hepatocellular carcinoma (HCC) cell-derived exosomes, lung cancer-derived exosomes, prostate cancer-derived ex …
The review is divided into two main parts, as follows: (1) role of exosomes in alternatively activating M2-like macrophages-breast cancer-de …
Malignant transformation of mature cystic teratoma of the ovary.
Atwi D, Kamal M, Quinton M, Hassell LA. Atwi D, et al. J Obstet Gynaecol Res. 2022 Dec;48(12):3068-3076. doi: 10.1111/jog.15409. Epub 2022 Sep 2. J Obstet Gynaecol Res. 2022. PMID: 36053141 Review.
Mature cystic teratoma is the most common ovarian germ cell neoplasm. Malignant transformation is a rare occurrence, accounting for 1.5%-2% of cases. Malignant changes can arise from any constituent tissue of a teratoma; however, squamous cell carci
Mature cystic teratoma is the most common ovarian germ cell neoplasm. Malignant transformation is a rare occurrence, accountin …
The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
Köbel M, Kang EY. Köbel M, et al. Int J Gynecol Pathol. 2021 Jan;40(1):32-40. doi: 10.1097/PGP.0000000000000725. Int J Gynecol Pathol. 2021. PMID: 33290354 Review.
Thereafter, the new interpretation of p53 IHC was quickly adapted for other purposes and similar accuracies were shown in endometrial carcinomas, vulvar squamous cell carcinomas, and ovarian mucinous tumors. However, it required further refinement of the p53 …
Thereafter, the new interpretation of p53 IHC was quickly adapted for other purposes and similar accuracies were shown in endometrial carcin …
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
Kassirian S, Hinton SN, Cuninghame S, Chaudhary R, Iansavitchene A, Amjadi K, Dhaliwal I, Zeman-Pocrnich C, Mitchell MA. Kassirian S, et al. Thorax. 2023 Jan;78(1):32-40. doi: 10.1136/thoraxjnl-2021-217959. Epub 2022 Feb 2. Thorax. 2023. PMID: 35110369
For primary thoracic malignancies, sensitivity was highest in lung adenocarcinoma (83.6%; 95% CI 77.7% to 89.6%) and lowest in lung squamous cell carcinoma (24.2%; 95% CI 17.0% to 31.5%) and mesothelioma (28.9%; 95% CI 16.2% to 41.5%). For malignancies with e …
For primary thoracic malignancies, sensitivity was highest in lung adenocarcinoma (83.6%; 95% CI 77.7% to 89.6%) and lowest in lung squam
Advanced primary vaginal squamous cell carcinoma: A case report and literature review.
Shen Y, Meng X, Wang L, Wang X, Chang H. Shen Y, et al. Front Immunol. 2022 Nov 22;13:1007462. doi: 10.3389/fimmu.2022.1007462. eCollection 2022. Front Immunol. 2022. PMID: 36483563 Free PMC article. Review.
Here, we report the case who was diagnosed with advanced, primary vaginal squamous cell carcinoma and underwent integrated treatment successfully. CASE INTRODUCTION: A 64-year-old Chinese woman underwent subtotal hysterectomy for uterine fibroids in 1998 and …
Here, we report the case who was diagnosed with advanced, primary vaginal squamous cell carcinoma and underwent integra …
313 results